Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
Stroes CI, Schokker S, Khurshed M, van der Woude SO, Mathôt RA, Slingerland M, de Vos-Geelen J, Zucchetti M, Matteo C, van Dijk E, Ylstra B, Thijssen V, Derks S, Godefa T, Dijksterhuis W, Breimer GE, van Delden OM, Verhoeven RH, Meijer SL, Bijlsma MF, van Laarhoven HW. Stroes CI, et al. Among authors: van laarhoven hw, van dijk e, van der woude so, van delden om. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221109196. doi: 10.1177/17588359221109196. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782751 Free PMC article.
Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts.
van der Heijden M, Miedema DM, Waclaw B, Veenstra VL, Lecca MC, Nijman LE, van Dijk E, van Neerven SM, Lodestijn SC, Lenos KJ, de Groot NE, Prasetyanti PR, Arricibita Varea A, Winton DJ, Medema JP, Morrissey E, Ylstra B, Nowak MA, Bijlsma MF, Vermeulen L. van der Heijden M, et al. Among authors: van dijk e, van neerven sm. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6140-6145. doi: 10.1073/pnas.1813417116. Epub 2019 Mar 8. Proc Natl Acad Sci U S A. 2019. PMID: 30850544 Free PMC article.
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment.
Beagan JJ, Bach S, van Boerdonk RA, van Dijk E, Thunnissen E, van den Broek D, Weiss J, Kazemier G, Pegtel DM, Bahce I, Ylstra B, Heideman DAM. Beagan JJ, et al. Among authors: van boerdonk ra, van dijk e, van den broek d. Lung Cancer. 2020 Jul;145:173-180. doi: 10.1016/j.lungcan.2020.04.039. Epub 2020 May 11. Lung Cancer. 2020. PMID: 32460198 Free article.
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Los-de Vries GT, de Boer M, van Dijk E, Stathi P, Hijmering NJ, Roemer MGM, Mendeville M, Miedema DM, de Boer JP, Rakhorst HA, van Leeuwen FE, van der Hulst RRWJ, Ylstra B, de Jong D. Los-de Vries GT, et al. Among authors: van der hulst rrwj, van dijk e, van leeuwen fe. Blood. 2020 Dec 17;136(25):2927-2932. doi: 10.1182/blood.2020005372. Blood. 2020. PMID: 33331925 Free article.
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.
van Dijk E, van Werkhoven E, Asher R, Mooi JK, Espinoza D, van Essen HF, van Tinteren H, van Grieken NCT, Punt CJA, Tebbutt NC, Ylstra B. van Dijk E, et al. Among authors: van essen hf, van werkhoven e, van tinteren h, van grieken nct. Int J Cancer. 2022 Oct 1;151(7):1166-1174. doi: 10.1002/ijc.34061. Epub 2022 May 23. Int J Cancer. 2022. PMID: 35489024 Free PMC article. Clinical Trial.
Molecular characterization of colorectal cancer related peritoneal metastatic disease.
Lenos KJ, Bach S, Ferreira Moreno L, Ten Hoorn S, Sluiter NR, Bootsma S, Vieira Braga FA, Nijman LE, van den Bosch T, Miedema DM, van Dijk E, Ylstra B, Kulicke R, Davis FP, Stransky N, Smolen GA, Coebergh van den Braak RRJ, IJzermans JNM, Martens JWM, Hallam S, Beggs AD, Kops GJPL, Lansu N, Bastiaenen VP, Klaver CEL, Lecca MC, El Makrini K, Elbers CC, Dings MPG, van Noesel CJM, Kranenburg O, Medema JP, Koster J, Koens L, Punt CJA, Tanis PJ, de Hingh IH, Bijlsma MF, Tuynman JB, Vermeulen L. Lenos KJ, et al. Among authors: van den bosch t, van dijk e, van noesel cjm. Nat Commun. 2022 Aug 4;13(1):4443. doi: 10.1038/s41467-022-32198-z. Nat Commun. 2022. PMID: 35927254 Free PMC article.
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer.
Ten Hoorn S, Mol L, Sommeijer DW, Nijman L, van den Bosch T, de Back TR, Ylstra B, van Dijk E, van Noesel CJM, Reinten RJ, Nagtegaal ID, Koopman M, Punt CJA, Vermeulen L. Ten Hoorn S, et al. Among authors: van den bosch t, van dijk e, van noesel cjm. Clin Colorectal Cancer. 2023 Mar;22(1):67-75. doi: 10.1016/j.clcc.2022.11.006. Epub 2022 Dec 5. Clin Colorectal Cancer. 2023. PMID: 36564280 Free article. Clinical Trial.
Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer.
Soeratram TTD, Biesma HD, Egthuijsen JMP, Meershoek-Klein Kranenbarg E, Hartgrink HH, van de Velde CJH, Mookhoek A, van Dijk E, Kim Y, Ylstra B, van Laarhoven HWM, van Grieken NCT. Soeratram TTD, et al. Among authors: van dijk e, van laarhoven hwm, van de velde cjh, van grieken nct. Mod Pathol. 2023 Sep;36(9):100218. doi: 10.1016/j.modpat.2023.100218. Epub 2023 May 12. Mod Pathol. 2023. PMID: 37182582 Free article.
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
van Garderen KA, Vallentgoed WR, Lavrova A, Niers JM, de Leng WWJ, Hoogstrate Y, de Heer I, Ylstra B, van Dijk E, Klein S, Draaisma K, Robe PAJT, Verhaak RGW, Westerman BA, French PJ, van den Bent MJ, Kouwenhoven MCM, Kros JM, Wesseling P, Smits M. van Garderen KA, et al. Among authors: van dijk e, van den bent mj. Neurooncol Adv. 2023 Nov 9;5(1):vdad149. doi: 10.1093/noajnl/vdad149. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024241 Free PMC article.
584 results